HBK Investments »

Apogee Therapeutics shares owned by HBK Investments

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by HBK Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $378M 2.9M 132.73

More positions owned by HBK Investments

Topbuild
Electronic Arts (EA)
Penumbra (PEN)
Norfolk Southern (NSC)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Kenvue (KVUE)
Warner Bros Discovery Com Ser A (WBD)
Bio-techne Corporation (TECH)
Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Teck Resources CL B (TECK)
Janus Henderson Group Ord Shs
Gamestop Corp Note 6/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for HBK Investments

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Rtw Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management
Paradigm Biocapital Advisors

View all funds holding Apogee Therapeutics